Topics in pediatric leukemia - Acute lymphoblastic leukemia

MedGenMed Medscape General Medicine

Volumn 7, Issue 1, 2005, Pages

  Esparza, Samuel D ^a   Sakamoto, Kathleen M ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CLOFARABINE; DEXAMETHASONE; GEMCITABINE; GLUCOCORTICOID; MERCAPTOPURINE; METHOTREXATE; NAVELBINE; THIOTEPA; TOPOTECAN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER THERAPY; CHILD; CHILDHOOD CANCER; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL TRIAL; ENVIRONMENTAL FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMAN; LEUKEMIA REMISSION; LEUKEMOGENESIS; MAINTENANCE THERAPY; PATHOPHYSIOLOGY; PROGNOSIS; RACE DIFFERENCE; SEX RATIO; UNITED STATES;

EID: 25144458985     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Pui CH, Pediatric oncology: acute lymphoblastic leukemia. Pediatr Clin North Am. 1997;44:831-846.
2. DiAngio GJ. Old man river. The flow of pediatric oncology. Hematol Oncol Clin North Am. 2001;15:599-607.
3. Woodruff TJ, Axelrad DA, Kyle AD, Nweke O, Miller GG, Hurley BJ. Trends in environmentally related childhood illnesses. Pediatrics. 2004;113(supp):1133-1140.
4. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2003 Sub (1973-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission. Available at: www.seer.cancer.gov Accessed February 4, 2005.
5. Spirito FR, Mancini M, Dermi V, et al. Trisomy 13 in a patient with common acute lymphoblasitc leukemia: description of a case and review of the literature. Cancer Genet Cytogenet. 2003;144:69-72.
6. Mertens AC, Wen W, Davies SM, et al. Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr. 1998;133:617-623.
7. Zipursky A, Poon A, Doyle J. Leukemia in Down syndrome: a review. Pediatr Hematol Oncol. 1992;9:139-149.
8. Shumacher HR. Acute leukemia. Clin Lab Med. 2002;22:153-192.
9. Reaman GH. Pediatric oncology: current views and outcomes. Pediatr Clin North Am. 2002;49:1305-1318.
10. Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002.
11. Greaves M. Childhood leukaemia. BMJ. 2002;324:283-287.
12. Lai R. Pathologic diagnosis of acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2000;14:1209-1235.
13. Martinez-Climent JA. Molecular cytogenetics of childhood hematological malignancies. Leukemia. 1997;11:1999-2021.
14. Lanzkowsky P. Manual of Pediatric Hematology and Oncology. 3rd ed. San Diego, Ca: Academic Press; 2000:359-372.
15. Silverman LB, Sallan SE. Newly diagnosed childhood acute lymphoblastic leukemia. Curr Opin Hematol. 2003;10:290-296.
16. Dworzak MN, Panzer-Grumayer ER. Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia. Leuk Lymphoma. 2003;44:1445-1455.
17. Craig FE. Bone marrow evaluation in pediatric patients. Semin Diagn Pathol. 2003;20:237-246.
18. Ma SK, Chan GC, Ha SY, et al. Clinical presentation, hematologic features, and treatment outcome of childhood acute lymphoblastic leukemia: a review of 73 cases in Hong Kong. Hematol Oncol. 1997;15:141-149.
19. Downing JR, Shannon KM. Acute leukemia: a pediatric perspective. Cancer Cell. 2002;2:437-445.
20. Turtureanu HE. Emergency care: the tumor lysis syndrome. Rev Med Chir Soc Med Nat Iasi. 2002;106:705-711.
21. Pui CH, Ribiero RC. International collaboration on childhood leukemia. Int J Hematol. 2003;78:383-389.
22. Pinkel D, Woo S. Prevention and treatment of meningeal leukemia in children. Blood. 1994;84:355-366.
23. Nathan PC, Maze R, Spegler B, et al. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42:24-29.
24. Chessells JM, Veys P, Kempski H, et al. Long term follow-up of relapsed childhood acute lymphoblastic leukemia. Br J Haematol. 2003;123:396-405.
25. Hayashi Y. Gene expression profiling in childhood acute leukemia: progress and perspectives. Int J Hematol. 2003;78:414-420.
26. Manera R, Ramirez I, Mullins J, Pinkel D. Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype. Leukemia. 2000;14:1354-1361.
27. Pui CH, Boyett JM, Rivera GK, et al. Long term results of total therapy studies 11, 12, and 13A for childhood acute lymphoblastic leukemia at St. Jude Children's Research Hospital. Leukemia. 2000;14:2286-2294.
28. Isaacs H. Fetal and neonatal leukemia. J Pediatr Hematol Oncol. 2003;25:348-361.
29. Plasschert SL, Kamps WA, Vellenga E, de Vries EG, de Bont ES. Prognosis in childhood and adult acute lymphoblastic leukemia: a question of maturation? Cancer Treat Rev. 2004;30:37-51.
30. Bradbury J. Brighter future for children with T-ALL. Lancet Oncol. 2003;4:650-652.
31. Pui CH, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003;290:2001-2007.
32. Rubnitz JE, Pui CH. Childhood acute lymphoblastic leukemia. Oncologist. 1997;2:374-380.
33. Green E, McConville CM, Powell JE, et al. Clonal diversity of Ig and TCR gene rearrangements identifies a subset of childhood B precursor acute lymphoblastic leukemia with increased risk of relapse. Blood. 1998;92:952-958.
34. Steinherz PG, Seibel NL, Ames M, et al. Phase I study of gemcitabine in children with relapsed or refractory leukemia. CCG 0955: a report from Children's Cancer Group. Leuk Lymphoma. 2002;43:1945-1950.
35. Kolb EA, Steinherz PG. A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. Leukemia. 2003;17:1967-1972.
36. Jeha S, Gandhi V, Chan KW, et al. Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood. 2004;103:784-789.
37. Hongo T, Okada S, Inoue N, et al. Two groups of Philadelphia chromosome-positive childhood acute lymphoblastic leukemia classified by pretreatment multidrug sensitivity or resistance in in vitro testing. Int J Hematol. 2002;76:251-259.